Recently, human CES2 and murine Ces2c have been discovered as metabolic lipases showing reduced mRNA expression in the liver of NASH patients and in obese mouse models exhibiting NAFLD [7,8,27,28]. Here, CES2 is linked to metabolic dysfunction-associated steatotic liver disease.